Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 11:32 AM ET

Biotechnology

Company Overview of CardioVascular BioTherapeutics, Inc.

Key Executives for CardioVascular BioTherapeutics, Inc.

NameBoard RelationshipsTitleAge
Daniel C. Montano No RelationshipsCo-Founder and Chief Executive Officer65
Mickael A. Flaa CPA4 RelationshipsPresident, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director61
Grant Gordon 4 RelationshipsCo-Founder and Vice Chairman53
John W. Jacobs Ph.D.No RelationshipsChief Operating Officer, Chief Scientific Officer and Vice President64
Nabil Dib M.D., M.Sc., F.A.C.C.9 RelationshipsPrincipal Investigator for Phase II Heart Trial--
View More Key Executives

CardioVascular BioTherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Calvin A. Wallen III 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Grant Gordon 4 RelationshipsCardioVascular BioTherapeutics, Inc.53
Mickael A. Flaa CPA 4 RelationshipsCardioVascular BioTherapeutics, Inc.61
Jon Ross 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Robert Schleizer 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
View All Board Members

CardioVascular BioTherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$480.0K
480.0K
363.7K
Bonus
Not meaningful
Total Short Term Compensation$480.0K
480.0K
450.1K
Total Value of Options
25.1M
Compensation as of Fiscal Year
CardioVascular BioTherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET
EMS Find, Inc. Announces Executive Changes
April 07, 2015 5:26 PM ET
HRG Group, Inc. Appoints Ehsan Zargar as General Counsel
April 03, 2015 8:44 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CardioVascular BioTherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.